Summary
Latest filing:
Elizabeth Cermak is Director of Moleculin Biotech, Inc. (MBRX). 2 SEC Form 4 filings on record going back to 2024, most recently on 14 November 2025.
Trading Pattern
InsiderAlpha's records for Elizabeth Cermak go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth Cermak files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jonathan P. Foster - of MBRX open-market activity in the last 12 months
- Walter V. Klemp - of MBRX open-market activity in the last 12 months
- Donald H. Picker - of MBRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Elizabeth Cermak?
Elizabeth Cermak is a corporate insider, tracked as Director of Moleculin Biotech, Inc. (MBRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Elizabeth Cermak last file a Form 4?
The most recent primary Form 4 on record is dated 14 November 2025, one of 2 filings going back to 2024.
Where can I see all of Elizabeth Cermak's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Elizabeth Cermak and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial